Skip to main content
Caplight Logo









Emerald

Emerald

Private
LondonHealthcare & Life Scienceshttps://withemerald.com/

Last Round

Pre Seed

Jan 29, 2026

Total Funding Raised

$2.86M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Emerald is a healthtech company that provides a preventive health platform integrating diagnostic blood testing, AI-driven analysis, and virtual GP consultations.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Healthcare Analytics

Business Model

B2C

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

preventive healthbiomarker testinglongevitybiohackinghealth membershiptelemedicinewearable dataprecision medicineemployee health benefitsdigital healthhealth optimizationblood screeninghealth analyticsconcierge medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emerald Comparables

Compare Emerald with similar companies based on industry and business-model similarity.

Emerald comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kyma Health
86%
Do Health
84%
Axo Longevity
82%

Emerald Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJan 29, 2026
AngelMay 14, 2025

Key People

Founding team and executive leadership

Anton Shchipanov

Co-Founder, CTO

Founding Team

Dan McNally

Co-Founder, Chief Medical Officer

Founding Team

Alexander Badalyan

Co-Founder, CEO

Founding Team

Emerald Investors

Notable investors and investment history

Emerald investors
InvestorRounds
Granatus VenturesPre Seed
Scientia VenturesAngel
Boost Capital PartnersPre Seed
Leafy TunnelAngel
Boost Capital PartnersPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 103% MoM, reaching 18.4K.

  • Jun 18, 2026

    Monthly visitors increased 153% MoM, reaching 9.1K.

Emerald Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Emerald Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Emerald's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range23
Year Founded2025
Last FundingJan 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?